Asarina Pharma: Solid preclinical package in Tourette’s

Research Note

2021-02-12

12:19

Redeye sees positive on the newly reported preclinical data in Tourette's syndrome. We are now ready to take a closer look at sepranolone in Tourette's.

AH

Anders Hedlund

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.